Cambridge, MA, United States of America

Alexander V Kel'in

Average Co-Inventor Count = 11.3

ph-index = 2

Forward Citations = 18(Granted Patents)

Forward Citations (Not Self Cited) = 2(Sep 21, 2024)

Location History:

  • Swampscott, MA (US) (2023)
  • Cambridge, MA (US) (2021 - 2024)


Years Active: 2021-2025

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Innovator in RNA Delivery: The Contributions of Alexander V. Kel'in

Introduction: Alexander V. Kel'in is a distinguished inventor based in Cambridge, Massachusetts, known for his significant contributions to the field of RNA technology. With a total of five patents to his name, Kel'in has made remarkable advancements in the area of gene silencing and RNA delivery mechanisms. His work has had a profound impact on the development of new therapeutic strategies, particularly in relation to RNA interference (RNAi).

Latest Patents: Among his latest patents is an invention focused on Extrahepatic Delivery, which involves a double-stranded iRNA agent that includes complementary antisense and sense strands along with lipophilic moieties conjugated to these strands. This innovative approach aims to enhance the efficacy of gene silencing treatments by facilitating the delivery of these agents to targeted cells. Another notable patent pertains to Carbohydrate Conjugate RNA Agents, which details an improved process for preparing carbohydrate conjugates and highlights their benefits in increasing the purity and delivery efficiency of iRNA agents in vivo.

Career Highlights: Alexander V. Kel'in currently works at Alnylam Pharmaceuticals, Inc., a leading company in the biotechnology sector specializing in RNAi therapeutics. His role at Alnylam has enabled him to contribute to pivotal developments in RNA delivery systems, furthering the company's mission to harness the power of RNAi for treating various diseases. His expertise and innovative thinking have positioned him as a key figure in the field.

Collaborations: Throughout his career, Kel'in has collaborated with prominent scientists and researchers, including Muthiah Manoharan and Kallanthottathil G Rajeev. These collaborations have facilitated the exchange of ideas and expertise, driving advancements in the development of novel RNA delivery technologies.

Conclusion: Alexander V. Kel'in's work exemplifies the spirit of innovation in biotechnology, particularly in RNA technology. With a focus on improving therapeutic delivery methods, his patents have the potential to revolutionize the way diseases are treated. As he continues to explore new frontiers in RNA research, Kel'in remains an influential figure whose contributions will undoubtedly shape the future of medical therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…